Development of B lymphopoiesis after allogeneic stem cell transplantation  by Winkler, J. et al.
isolated thymocytes and on thymocyte development in organ cul-
tures. We observed a dose dependent increase in the survival of
isolated day 15 fetal thymocytes. To examine the effect of rhGH in
vitro we ﬁrst developed a serum-free fetal thymic organ culture
assay to eliminate serum as an additional exogenous source of GH
and IGF-1 in the system. In fetal thymic organ cultures performed
in serum-free conditions, the addition of 10–100 ng/ml of rhGH
resulted in signiﬁcant increases in total thymic lobe cellularity,
CD4CD8, and CD4CD8 thymocytes at day 13 of fetal thy-
mic organ culture (Student’s t-test p
0.01, p
0.005, p
0.05,
respectively). In contrast, the addition of 50 ng/ml rhIL-7 results
promotes survival of CD4CD8 thymocytes and exerts a block in
differentiation to CD4CD8 cells in this culture system. These
results demonstrate that promotion of thymopoiesis associated
with rhGH administration after bone marrow transplant may be
due, at least in part, by direct action of rhGH on the thymus and
thymocytes and that mechanism of action appears to differ from
IL-7.
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Long term engraftment after stem cell transplantation is depen-
dent on pluripotent hematopoietic stem cells capable to multilin-
eage reconstitution. The engraftment and prolonged repopulation
of B lymphoid progenitor cells is dependent on pluripotent hema-
topoietic stem cells. Recently, we could demonstrate that a high
number of B cell progenitors are detectable in the bone marrow
from patients both after allogeneic PBSCT and after allogeneic
BMT. The percentage of CD19CD10 cells pro-B/pre-B cells
showed a high variability and ranged from 0 to 98% of all B
lymphocytes. No statistical difference of precursor B lymphocytes
between BM recipients and PBSC recipients was found. In micro-
satellite analysis, both in PBSC recipients and in BM recipients the
B cell precursors were derived exclusively from the donor. The aim
of the study was to identify predictors of B lymphopoiesis in the
bone marrow after stem cells transplantation. A stepwise, multiple
regression analysis was performed. The stem cell source, BM or
PBSC, the occurrence of GVHD, the conditioning with TBI and
the immunosuppression with ATG were entered as categorical
variables, whereas the BM collection time after transplantation, the
age of the donor and of the recipient, the transplanted stem cell
quantity and the T cell content of the BM sample served as
continuous variables. The time elapsed after transplantation when
BM was collected (p0.002) as well as severe GVHD (aGVHD
grade III/IV or extensive cGVHD) at the time point of sample
analysis (p0.036) were identiﬁed as parameters with an indepen-
dent inﬂuence on the percentage of B cell precursors. The highest
percentage of precursor B cells was found during the ﬁrst year after
transplantation. However, patients with severe GVHD showed the
lowest percentage of precursor B cells. The hyperactive B lympho-
poiesis in the ﬁrst year after transplantation was in contrast to the
low number of circulating B cells. In addition, these studies show,
that G-CSF mobilized PBSC contain sufﬁcient hematopoietic
stem cells capable of long term reconstitution of the B cell com-
partment.
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MAJOR CYTOTOXIC PATHWAYS ARE REQUIRED FOR EFFECTIVE RESIS-
TANCE AGAINST HEMATOPOIETIC ALLOGRAFTS BY EFFECTOR CELLS
DERIVED FROM NAI¨VE BUT NOT MEMORY RECIPIENT T CELLS
Zimmerman, Z.F.; Levy, R.B. University of Miami School of Medicine,
Miami, FL.
T cell mediated resistance to engraftment must be prevented
following clinical BMT particularly after T cell depletion and
reduced intensity conditioning. Following sensitization to donor
alloantigen, mice deﬁcient in perforin and FasL (B6-cdd) mount a
vigorous T cell mediated resistance to high numbers of donor BM,
despite the simultaneous blockade/absence of TRAIL, TL1a,
TWEAK, and TNFR1. We are investigating host cytotoxic path-
ways post-BMT to determine if their signiﬁcance differs depend-
ing on whether effector cells are derived from naı¨ve or memory T
cell populations. An ex-vivo model of T effector cell-PC interaction
was developed to address this issue. BM cells were cultured with in
vitro generated effector cells in the presence of SCF, TPO, and
Flt3L for 48 hrs. and then assessed for remaining CFU-GM levels.
Unsensitized B6-wt or B6 cdd spleen/LN cells were stimulated
against H-2d alloantigens. Effector cells from B6-wt or B6-cdd
anti-BALB.B cell lines initiated from antigen sensitized mice were
utilized as a memory-like population. No population inhibited
syngeneic B6 BM CFU activity. BALB/c CFU activity was mark-
edly diminished following incubation with B6-wt effectors but was
not diminished following co-culture with B6-cdd effectors. In
marked contrast, when effector cells from B6-wt and B6-cdd cell
lines were examined, both populations speciﬁcally and profoundly
inhibited BALB.B CFU-GM activity. These latter results are con-
sistent with our ﬁndings reporting strong BMT resistance in situ in
cytotoxically normal and defective sensitized recipients. To begin
addressing the role of cytotoxicity in resistance by effector cells
derived from naı¨ve T cells in vivo, MHC identical C3H.SW BM
was transplanted into cytotoxically normal or defective non-my-
eloablatively (5.5 TBI) conditioned recipients. Preliminary ﬁnd-
ings indicate that “naı¨ve” B6-perforin deﬁcient and B6 CD95L
defective recipients maintain their capacity to rigorously reject
allogeneic BM grafts, however, resistance in B6-cdd mice is weak-
ened. Moreover, failure to reject allogeneic bcl-2 tg BM in non-
donor sensitized recipients supports a requirement for cytotoxic
function by effector T cells derived from naı¨ve T cells. In total,
these data are consistent with the notion that resistance mediated
by effector cells derived from memory—but not naı¨ve—T cells
does not require a contribution by major cell-mediated cytotoxic
pathways.
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EX VIVO GENERATED MYELOID PROGENITORS PROTECT MICE FROM
LETHAL IRRADIATION
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Wahedi, M.; Fong, T. Cellerant Therapeutics, Palo Alto, CA.
We are investigating the potential application of human myeloid
progenitors (MP) as a novel therapy to enhance immune functions
and provide temporary hematopoietic recovery for victims who are
exposed to life-threatening doses of radiation or high-dose chem-
ical or radio-myeloablation as component of their medical treat-
ment. The myeloid progenitor pool, in both mouse and human
bone marrow, has been characterized using cell surface markers.
Myeloid progenitors include Common Myeloid Progenitors
(CMP), Granulocyte Macrophage Progenitors (GMP) and
Megakaryocyte Erythroid Progenitors (MEP). The CMP and
MEP have been found to provide radioprotection in a syngeneic
mouse model [J Clin Invest. 109:1579–85 (2002)]. We are exam-
ining whether MP also have radioprotective qualities in an alloge-
neic transplantation model. Myeloid progenitors were either
sorted from mouse bone marrow (CD117, CD90.1, Linneg/low
Sca-1) or derived in culture from puriﬁed KTLS mouse HSC
(CD117, CD90.1low, Linneg/low Sca-1). Sorted MPs provide
good radioprotection in the syngeneic and matched unrelated
transplantation settings. While sorted MPs provide only limited
protection in an allogeneic model, progenitors derived ex vivo
protect allogeneic recipients from radiation induced death. The
added burden of opportunistic infection often complicates recov-
ery during periods of neutropenia. MPs have also been shown to
provide protection against otherwise lethal fungal infections in
neutropenic mice [Blood 100:4660–7 (2002)]. We are determining
if cultured derived MP provide protection from both hematopoi-
etic failure and fungal infection. This research is aimed at devel-
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